References
- Keay SD, Liversedge NH, Mathur ES, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol. 1997;104:521–7.
- Saldeen P, Källén K, Sundström P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand. 2007;86:457–61.
- Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003;9:61–76.
- Anderson R, Kinniburgh T, Baird DT. Preliminary experience of the use of a gonadotrophin releasing hormone antagonist ikn ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod. 1999;14:2665–8.
- Fridén B, Nilsson L. Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization. Acta Obstet Gynecol Scand. 2005;84:812–16.
- Humaidan P, Bungum L, Bungum M, Hald F, Agerholm I, Blaabjerg J, Yding Andersen C, Lindenberg S. Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol. Reprod Biomed Online. 2005;(11):679–84.
- van Poppel H, Nilsson S. Testosterone surge: rationale for gonadotropin-releasing hormone blockers? Urology. 2008;71:1001–6.
- Wong SL, Lau DT, Baughman SA, Menchaca D, Garnick MB. Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer. Clin Pharmacol Ther. 2003;(73):304–11.
- Valiente C, Romero GG, Corrada Y, de la Sota PE, Hermo G, Gobello C. Interruption of the canine estrous cycle with a low and a high dose of the GnRH antagonist acyline. Theriogenology. 2009;71:408–11.
- Malmusi S, La Marca A, Giulini S, Xella S, Tagliasacchi D, Marsella T, Volpe A. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril. 2005;(84):402–6.
- Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril. 2009;92:481–5.
- Weitzman VN, Engmann L, Diluigi A,Maier D, Nulsen J, Benadiva C. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Fertil Steril. 2009;92:226–30.
- Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril. 2005;83:331–5.